Skip to main content
. 2022 Jul 17;15(7):883. doi: 10.3390/ph15070883

Table 2.

Mean reduction in all parameters analysed.

Baseline 4 Months 8 Months 12 Months 16 Months 20 Months 24 Months 28 Months 32 Months 36 Months
meanNRSpp 8.6 3.1 2.8 2.7 2.34 1.88 2.4 2.14 1.78 1.73
sd 1.7 Sd 2.5 Sd 2.3 Sd 2.3 Sd 2.4 Sd 2.1 Sd 2.4 Sd 2.3 Sd 2.2 Sd 2.3
meanNRSsd 7 1 0.6 0.9 0.6 1.9 0.6 0.7 0.3 0
Sd 3 Sd 2.1 Sd 1.8 Sd 2 Sd 1.5 Sd 2.1 Sd 1.9 Sd 1.8 Sd 1 Sd 0
meanEASI 23.2 3.7 2.8 2.7 2.3 1.3 1.4 1.7 1.5 1.6
Sd 10.8 Sd 5.3 Sd 3.7 Sd 3.8 Sd 4.1 Sd 1.7 Sd 2 Sd 4 Sd 3.9 Sd 2
meanDLQI 14.9 4.6 4 3.5 2.7 2.4 3.2 2.5 2.6 1.2
Sd 7 Sd 5 Sd 5 Sd 4 Sd 3.7 Sd 3 Sd 4.2 Sd 3.2 Sd 4.8 Sd 2.4
meanPOEM 20.6 7.3 6.7 6.2 5.7 4.8 5.4 4.9 4.1 3.8
Sd 6.1 Sd 5.8 Sd 5.9 Sd 5.4 Sd 5.8 Sd 5.4 Sd 5.4 Sd 5.5 Sd 5 Sd 5.2
meanLDH 320.9 236.3 222.4 214.9 201.2 198.9 211.3 203 212.7 198.3
Sd 144.2 Sd 96 Sd 81.1 Sd 78.7 Sd 70.3 Sd 73.9 Sd 82.6 Sd 59.8 Sd 65.8 Sd 61.6
mean Eosinophiles 2.1 0.64 0.59 0.55 2.07 0.5 1.94 0.35 0.32 0.38
Sd 19.6 Sd 0.8 Sd 1 Sd 0.9 Sd 17.3 Sd 1.1 Sd 15.3 Sd 0.3 Sd 0.2 Sd 0.2
mean tot-IgE 3239.2 1923 1166 817.8 875.8 551.7 516.9 431.8 379.7 209.3
Sd 5020.4 Sd 3138.4 Sd 1768 Sd 1220.7 Sd 2366.2 Sd 869.3 Sd 805.7 Sd 728 Sd 634.4 Sd 308.5